Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673711 · ClinicalTrials.gov registry record
Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer
A clinical trial of Lung Cancer and Tobacco Use Disorder, sponsored by University of Minnesota.
- Completed
- Registry status
- 350
- Enrollment target
- 3
- Study locations
NCT01673711: Completed study of Lung Cancer and Tobacco Use Disorder, sponsored by University of Minnesota.
NCT01673711 is a study of Lung Cancer and Tobacco Use Disorder that has completed, run by University of Minnesota. The registered enrollment target is 350 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (63% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01673711, a study of Lung Cancer and Tobacco Use Disorder, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial studies deuterated phenanthrene tetraol in smokers who are at high risk for lung cancer. Studying samples of urine in the laboratory from smokers who are at high risk for lung cancer may help doctors learn more about biomarkers related to cancer.
Primary Outcome
A multiple regression analysis will be performed including explanatory variables such as lesion status, presence/absence of chronic obstructive pulmonary disease (COPD) or asbestos, duration of smoking, smoking intensity, age, and gender.
Conditions Studied
Interventions
- DRUG deuterated phenanthrene tetraol
- DRUG pharmacological study
- DRUG laboratory biomarker analysis
Study Locations (3)
Minnesota
- Mayo Clinic - Rochester
New York
- Roswell Park Cancer Institute - Buffalo
British Columbia
- BC Cancer Agency - Vancouver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2012-07 |
| Est. Completion | 2019-09-30 |
What the finished NCT01673711 record still lists
NCT01673711 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (63% lower).
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which deuterated phenanthrene tetraol is the first listed.
NCT01673711 reports a single indexed study location in Minnesota, New York, British Columbia.
Frequently Asked Questions
What is clinical trial NCT01673711 about?
NCT01673711 is a clinical study titled "Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer". This clinical trial studies deuterated phenanthrene tetraol in smokers who are at high risk for lung cancer. Studying samples of urine in the laboratory from smokers who are at high risk for lung cancer may help doctors learn more about biomarkers related to cancer.
What is the current status of trial NCT01673711?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2012-07. Estimated completion is 2019-09-30.
What conditions does trial NCT01673711 study?
This clinical trial studies the following conditions: Lung Cancer, Tobacco Use Disorder, Squamous Lung Dysplasia.
What interventions are being tested in trial NCT01673711?
The interventions under investigation include: deuterated phenanthrene tetraol (DRUG), pharmacological study (DRUG), laboratory biomarker analysis (DRUG).
Who is sponsoring clinical trial NCT01673711?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01673711 being conducted?
This trial has 3 study locations across Minnesota, New York, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01673711's enrollment target sits among peer trials
350 92nd of 409 higher than 318 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia